Idiopathic pulmonary fibrosis trials in Taiwan

In Taiwan 6 Also abroad 111

6 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 2Taking people
Study to Evaluate the Efficacy, Safety, and Tolerability of PIPE 791 in Subjects With Idiopathic Pulmonary Fibrosis
Where
Changhua, Kaohsiung City, New Taipei City, Taichung, Taipei
Age
40 years and over
People
324 worldwide
Run by
Contineum Therapeutics
See details and how to joinNCT07284459 · EU 2025-521901-42-00
Phase 3Not yet taking people in Taiwan
Long-term Extension Study to Evaluate Safety and Tolerability of Admilparant in Participants With Pulmonary Fibrosis
Where
Kaohsiung City, Taichung, Taipei
Age
18 years and over
People
2,380 worldwide
Run by
Bristol-Myers Squibb
See details and how to joinNCT07441408 · EU 2025-522373-10-00
Phase 2Taking people
A Phase IIb Study to Evaluate AZD8965 in Participants With IPF.
Where
Kaohsiung City, Taichung, Taipei, Taoyuan, Yunlin
Age
40 years and over
People
359 worldwide
Run by
AstraZeneca
See details and how to joinNCT07652658
Phase 3Enrolling by invitation
Extension Study of Inhaled Treprostinil in Subjects With Fibrotic Lung Disease
Where
Kaohsiung City, New Taipei City, Taipei
Age
40 years and over
People
1,850 worldwide
Run by
United Therapeutics
See details and how to joinNCT04905693
Phase 2Taking people
Study of ABBV-142 to Assess Adverse Events and Change in Disease Activity in Adult Participants With Idiopathic Pulmonary Fibrosis
Where
Kaohsiung City, Taichung, Taipei, Taoyuan City
Age
40 years and over
People
165 worldwide
Run by
AbbVie
See details and how to joinNCT07230288 · EU 2024-518013-25-00
Phase 3Taking people
Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
Where
Kaohsiung City, Taichung
Age
18 years and over
People
698 worldwide
Run by
United Therapeutics
See details and how to joinNCT05943535 · EU 2023-504904-26-00